Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00875199 · ClinicalTrials.gov registry record · Phase 2
Contingency Management to Promote Weight Loss in Low Income Adults
A Phase 2 study of Overweight, sponsored by UConn Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00875199: Completed Phase 2 study of Overweight, sponsored by UConn Health.
NCT00875199 is a Phase 2 study of Overweight that has completed, run by UConn Health. The registered enrollment target is 30 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00875199, a Phase 2 study of Overweight, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate the feasibility and provide preliminary evidence for efficacy of a 12-week contingency management intervention to promote weight loss in overweight and obese low income adults in a community-based clinic. The study has three primary goals: (a) to determine if the contingency management treatment can be effectively applied to a new application, weight loss; (b) to obtain preliminary evidence for contingency management's efficacy in promoting weight loss and improving treatment retention, diet quality, physical activity levels, and self efficacy; and (c) to identify barriers and challenges to implementing contingency management for weight loss among low income patients.
Conditions Studied
Interventions
- BEHAVIORAL contingency management
- BEHAVIORAL weight loss manual-guided individual therapy sessions
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
What the finished NCT00875199 record still lists
NCT00875199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which contingency management is the first listed.
NCT00875199 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00875199 about?
NCT00875199 is a clinical study titled "Contingency Management to Promote Weight Loss in Low Income Adults". This study is designed to evaluate the feasibility and provide preliminary evidence for efficacy of a 12-week contingency management intervention to promote weight loss in overweight and obese low income adults in a community-based clinic. The study has three primary goals: (a) to determine if the c...
What is the current status of trial NCT00875199?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2009-03. Estimated completion is 2010-03.
What conditions does trial NCT00875199 study?
This clinical trial studies the following conditions: Overweight.
What interventions are being tested in trial NCT00875199?
The interventions under investigation include: contingency management (BEHAVIORAL), weight loss manual-guided individual therapy sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT00875199?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00875199 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00875199's enrollment target sits among peer trials
30 168th of 197 higher than 28 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
RECRUITING · Phase 2
-
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
RECRUITING · Phase 2
-
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
RECRUITING · Phase 2
-
Semaglutide for Post-Smoking Cessation Weight Management
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia